Allegations of a shocking drug-related scandal within the Philadelphia Department of Public Health (PDPH) have surfaced, triggering calls for the resignation of its director, Dr. Kathleen Brady. A former employee, Ervin Malik Simmons, claims to have witnessed a toxic workplace environment that included drug trafficking and abusive behavior.

Simmons, who worked as a Community Engagement and Marketing Coordinator in the department’s Division of HIV Health, penned a detailed six-page open letter outlining his troubling experiences. His termination in October—a dismissal he alleges was in retaliation for raising concerns—highlights a dire situation at the health agency.

Describing an environment marked by harassment and a lack of guidance, Simmons revealed that he was subjected to both personal and professional turmoil, exacerbated by a volatile romantic relationship with a colleague. “I was just trying to do my job and protect myself, but everything seemed to spiral out of control under Dr. Brady’s leadership,” Simmons stated.

Upon joining the department, Simmons claims he was warned of a toxic atmosphere. He argues that a lack of effective diversity training and poor management contributed to the hostility, inhibiting employees’ ability to perform their duties effectively.

Furthermore, Simmons expressed concerns that marketing campaigns aimed at minority groups were led predominantly by cisgender white women, leading to a significant disconnect in messaging. His attempts to offer constructive feedback were reportedly met with exclusion from key projects.

The letter also makes alarming allegations of racism and sexual misconduct within the department. Simmons recounted a specific incident where a fair-skinned Latino colleague referred to Afro-Brazilians in derogatory terms.

The situation escalated when Simmons began dating Antonio “Toni” McFadden, a field coordinator within the department. He detailed a troubling dynamic marked by intimate partner violence and drug use. Specifically, Simmons alleged that McFadden introduced him to cocaine and was involved in using drug incentives with research participants.

In his letter, Simmons claimed McFadden had arranged with a drug dealer to trade $50 gift cards—which the department provided to participants for research studies—for cocaine. This troubling method reportedly included offering the drug as a reward for participation.

Further allegations suggest that McFadden engaged in sexual relationships with study participants, causing Simmons to fear the ramifications for public health among those affected by HIV. “Cocaine and drug use can lead to behaviors that increase vulnerability to HIV, which makes this whole situation even more alarming,” Simmons noted.

Despite his attempts to alert Dr. Brady and human resources about McFadden’s activities and the abusive relationship, Simmons claims his reports were largely ignored. “It felt like I was shouting into a void,” he said, emphasizing that he was not kept informed during a brief investigation into his claims.

After ending his relationship with McFadden, Simmons sought help for the trauma he experienced, resulting in a PTSD diagnosis. His request for accommodations was denied, leading to his termination instead of the support he needed.

The shocking revelations come at a time when Mayor Cerrelle Parker is facing increasing criticism since taking office as Philadelphia’s first female mayor. Beyond the allegations from Simmons, her administration has been scrutinized over its handling of diversity, equity, and inclusion (DEI) initiatives.

Residents have expressed frustration over proposed tax increases, return-to-office mandates for city workers, and the city’s overall approach to employee grievances. Some former employees have even filed federal lawsuits alleging discrimination and mishandling of complaints.

The fallout from Simmons’ allegations could force a reevaluation of standards within the PDPH. Calls for accountability from concerned residents and advocacy groups are growing louder, pressing for action from Mayor Parker.

This situation not only raises serious questions about the management practices at the PDPH but also about the broader implications for public health policy and community relations in Philadelphia. Simmons’ experience is a reminder of the issues that can fester in silence without proper oversight.

As the city grapples with these allegations, the future of Dr. Brady’s leadership at the health department hangs in the balance. The community awaits a response from city officials amidst rising concerns regarding the implications of these claims for public trust in health initiatives.

With public health agencies under increasing scrutiny, Simmons’ letter serves as a critical wake-up call, urging greater transparency and accountability in how such allegations are handled moving forward.